Trial Profile

A phase 3 trial of B244 Topical Spray for treatment of atopic dermatitis and associated pruritus

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 12 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs B 244 (Primary)
Indications Atopic dermatitis; Pruritus
Focus Registrational; Therapeutic Use
Sponsors AOBiome

Most Recent Events

05 Jan 2024 According to an AOBiome media release, company is in process of planning global Phase 3 studies for B244 in Atopic Dermatitis, for which it aims to start recruiting patients in the second half 2024. The Japanese portion of the Phase 3 trials will be run in Japan by Maruho.
20 Sep 2022 According to an AOBiome media release, the company plans to start recruiting patient in this study in 2023.
25 Feb 2022 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com